|By PR Newswire||
|August 20, 2014 10:58 AM EDT||
DUBLIN, Aug. 20, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020" report to their offering.
A new report titled, "Global biosimilars/follow-on-biologics market (types, applications and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020", suggests that the global biosimilars market would reach $35 billion by 2020 from the estimated $1.3 billion in 2013. Deeper penetration with clearer regulatory pathways in developed markets and higher efficacy & safety in emerging markets will back the market growth during the forecast period.
Over 10 blockbuster biologics with annual sales of $60 billion are facing patent expiries in Europe and in the U.S. during the next four years. Top pharmaceutical manufacturing brands are repositioning their strategic agendas from approvals to product launches to gain market capitalization. "Biosimilars developers have been using emerging markets with less intellectual property protection as their launch pad for established markets" say AMR analysts.
Key Topics Covered:
CHAPTER 1 INTRODUCTION
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET OVERVIEW
CHAPTER 4 GLOBAL BIOSIMILARS/FOLLO-ON-BIOLOGICS MARKET BY TECHNOLOGY
CHAPTER 5 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET BY PRODUCT TYPE
CHAPTER 6 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET BY APPLICATIONS
CHAPTER 7 GLOBAL BIOSIMILARS / FOLLOW-ON-BIOLOGICS MARKET BY SERVICES
CHAPTER 8 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET BY GEOGRAPHIES
CHAPTER 9 KEY PRODUCTS AND RECENT ACTIVITIES BY GEOGRAPHY
CHAPTER 10 COMPANY PROFILES
- Biogen idec Inc
- Genentech (Roche Group)
- LG Life Sciences
- Merck Serono (Merck Group)
- Novartis (Sandoz)
- Synthon Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
For more information visit http://www.researchandmarkets.com/research/qftx4c/global
Media Contact: Laura Wood, +353-1-481-1716, [email protected]
Data is an unusual currency; it is not restricted by the same transactional limitations as money or people. In fact, the more that you leverage your data across multiple business use cases, the more valuable it becomes to the organization. And the same can be said about the organization’s analytics. In his session at 19th Cloud Expo, Bill Schmarzo, CTO for the Big Data Practice at EMC, will introduce a methodology for capturing, enriching and sharing data (and analytics) across the organizati...
Sep. 29, 2016 03:15 PM EDT Reads: 1,762
Sep. 29, 2016 03:00 PM EDT Reads: 2,743
Sep. 29, 2016 03:00 PM EDT Reads: 2,949
Sep. 29, 2016 02:00 PM EDT Reads: 1,135
Sep. 29, 2016 02:00 PM EDT Reads: 3,935
Sep. 29, 2016 02:00 PM EDT Reads: 3,594
Sep. 29, 2016 02:00 PM EDT Reads: 4,171
Sep. 29, 2016 01:45 PM EDT Reads: 1,773
Sep. 29, 2016 01:45 PM EDT Reads: 1,114
Sep. 29, 2016 01:30 PM EDT Reads: 4,449
Sep. 29, 2016 01:15 PM EDT Reads: 320
Sep. 29, 2016 01:15 PM EDT Reads: 2,920
Sep. 29, 2016 01:15 PM EDT Reads: 3,017
Sep. 29, 2016 01:00 PM EDT Reads: 1,691
Sep. 29, 2016 12:45 PM EDT Reads: 5,134